Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Launched by ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST · Jun 17, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Chest CT Biomarkers as Prognostic Predictors in SSc-ILD," is looking at how certain imaging tests can help doctors predict the progression of a lung disease related to systemic sclerosis (SSc). The researchers want to find out if specific markers seen in chest scans can indicate how the disease will develop over time, including the risk of new complications and overall survival.

To participate in this study, you must be at least 18 years old and have been diagnosed with systemic sclerosis. Additionally, you need to have had a special type of chest scan (called HRCT) done between January 1, 1990, and December 31, 2019. The trial is not currently recruiting participants, but if you qualify, you may contribute to important research that could improve understanding and treatment of lung issues in systemic sclerosis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosed with SSc
• • ≥18 years old
• • HRCT between 01/01/1990 and 31/12/2019
• Exclusion Criteria:
• • Patients who do not have SSc
• • \<18 years old
• • lack of availability of HRCT imaging data